Indies Pharma Jamaica Ltd (INDIES)

Currency in JMD
3.20
+0.02(+0.63%)
Closed·

INDIES Financial Summary

Key Ratios

P/E Ratio0
Price/Book0
Debt / Equity67.09%
Return on Equity19.66%
Dividend Yield7.27%
EBITDA303.32M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/10
2017
31/10
2018
31/10
2019
31/10
2020
31/10
2021
31/10
2022
31/10
2023
31/10
2024
31/10
* In Millions of JMD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.19%
Dividend Yield
7.27%
Industry Median 2.82%
Annualised payout
0.25
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jun 13, 2025
EPS / Forecast
0.05 / --
Revenue / Forecast
270.00M / --
EPS Revisions
Last 90 days

FAQ

What were Indies Pharma's earnings for the latest quarter?

The Indies Pharma EPS (TTM) is 0.19. Indies Pharma reported sales of 270.00, net income of 63.77, and EPS of 0.05 for the latest quarter.

What was Indies Pharma's net income for the latest quarter?

Indies Pharma's net income for the latest quarter was 63.77.

How did Indies Pharma's performance compare year-over-year in the latest quarter?

The company's revenue moved from 325.83 in the previous quarter to 270.00 in the latest quarter, and net income moved from 74.19 to 63.77 compared to the previous quarter.

What is Indies Pharma's net profit margin on a TTM basis?

Indies Pharma's trailing twelve months (TTM) net profit margin is 21.72%.

How does Indies Pharma's debt to equity ratio compare to industry standards?

Indies Pharma's total debt-to-equity ratio is 67.09%.

What is Indies Pharma's return on investment on a TTM basis?

Indies Pharma's trailing twelve months (TTM) return on investment (ROI) is 19.66%.

Did Indies Pharma gain or lose cash last quarter?

In the latest quarter, Indies Pharma's net change in cash was 45.46 million.

What were Indies Pharma's total assets and liabilities in the latest quarter?

As of the latest quarter, Indies Pharma reported total assets of 2,461.73 million and total liabilities of 966.17 million.

How has Indies Pharma's total revenue grown this year?

Indies Pharma's total revenue was 325.83 in the previous quarter and 270.00 in the latest quarter.

What is Indies Pharma's gross margin on a TTM basis?

Indies Pharma's trailing twelve months (TTM) gross margin is 60.32%.

What was Indies Pharma's revenue per share for the latest quarter?

Indies Pharma's revenue per share for the latest quarter was 149.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.